Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

Gastroenterology

Volumn 152, Issue 4, 2017, Pages 799-811.e7

  Ott, Stephan J ^a   Waetzig, Georg H ^b   Rehman, Ateequr ^c   Moltzau Anderson, Jacqueline ^c,d   Bharti, Richa ^c   Grasis, Juris A ^e   Cassidy, Liam ^c   Tholey, Andreas ^c   Fickenscher, Helmut ^c   Seegert, Dirk ^b   Rosenstiel, Philip ^c   Schreiber, Stefan ^a,c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b CONARIS Research Institute AG ^*  (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

^e SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Fecal Transplant; Feces; Intestinal Microbiome; Microbe

Indexed keywords

BACTERIAL DNA; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CYCLOSPORIN; GLUTAMATE DEHYDROGENASE; METRONIDAZOLE; PROTEOME; RIFAXIMIN; RNA 16S; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BIOLOGICAL THERAPY; BODY TEMPERATURE; CANCER DIAGNOSIS; CANCER SURGERY; CAUCASIAN; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON CANCER; COMMUNITY STRUCTURE; COMORBIDITY; CONTROLLED STUDY; DEFECATION HABIT; DIARRHEA; DIVERTICULITIS; ENZYME IMMUNOASSAY; FECAL FILTRATE TRANSFER; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROSCOPY; GENE SEQUENCE; HUMAN; INTESTINE FLORA; KIDNEY GRAFT; MALE; MIDDLE AGED; ORTHOPEDIC SURGERY; PATHOGENESIS; PHYLOGENY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPTICEMIA; SIGMOIDECTOMY; STAPHYLOCOCCUS INFECTION; SYNDROME X; TOBACCO DEPENDENCE; TREATMENT RESPONSE; VIRUS LIKE AGENT; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FILTRATION; GASTROINTESTINAL TRACT; INSTRUMENT STERILIZATION; METABOLISM; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RECURRENT DISEASE; VIROLOGY;

AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FILTRATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROTEOME; RECURRENCE; STERILIZATION;

EID: 85014315210     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.11.010     Document Type: Article

References (54)

1. 1 Bakken, J.S., Borody, T., Brandt, L.J., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9 (2011), 1044–1049.
2. 2 Gough, E., Shaikh, H., Manges, A.R., Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53 (2011), 994–1002.
3. 3 Borody, T.J., Khoruts, A., Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9 (2012), 88–96.
4. 4 Hamilton, M.J., Weingarden, A.R., Sadowsky, M.J., et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107 (2012), 761–767.
5. 5 van Nood, E., Vrieze, A., Nieuwdorp, M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368 (2013), 407–415.
6. 6 Kassam, Z., Lee, C.H., Yuan, Y., et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108 (2013), 500–508.
7. 7 Youngster, I., Russell, G.H., Pindar, C., et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312 (2014), 1772–1778.
8. 8 Allen-Vercoe, E., Reid, G., Viner, N., et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26 (2012), 457–462.
9. 9 Drekonja, D., Reich, J., Gezahegn, S., et al. Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162 (2015), 630–638.
10. 10 Cammarota, G., Masucci, L., Ianiro, G., et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 41 (2015), 835–843.
11. 11 Fischer, M., Sipe, B.W., Rogers, N.A., et al. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 42 (2015), 470–476.
12. 12 Satokari, R., Mattila, E., Kainulainen, V., et al. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection–an observational cohort study. Aliment Pharmacol Ther 41 (2015), 46–53.
13. 13 Costello, S.P., Conlon, M.A., Vuaran, M.S., et al. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. Aliment Pharmacol Ther 42 (2015), 1011–1018.
14. 14 Kelly, C.R., Kahn, S., Kashyap, P., et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149 (2015), 223–237.
15. 15 Agrawal, M., Aroniadis, O.C., Brandt, L.J., et al. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals. J Clin Gastroenterol 50 (2016), 403–407.
16. 16 Lee, C.H., Steiner, T., Petrof, E.O., et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315 (2016), 142–149.
17. 17 Khoruts, A., Sadowsky, M.J., Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol 13 (2016), 508–516.
18. 18 Smits, L.P., Bouter, K.E., de Vos, W.M., et al. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145 (2013), 946–953.
19. 19 Petrof, E.O., Khoruts, A., From stool transplants to next-generation microbiota therapeutics. Gastroenterology 146 (2014), 1573–1582.
20. 20 Paramsothy, S., Borody, T.J., Lin, E., et al. Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21 (2015), 1600–1606.
21. 21 Kelly, C.R., Ihunnah, C., Fischer, M., et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109 (2014), 1065–1071.
22. 22 Mandalia, A., Ward, A., Tauxe, W., et al. Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile. Int J Colorectal Dis 31 (2016), 1059–1060.
23. 23 Ridaura, V.K., Faith, J.J., Rey, F.E., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
24. 24 Wang, X., Yang, Y., Huycke, M.M., Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut 64 (2015), 459–468.
25. 25 Alang, N., Kelly, C.R., Weight gain after fecal microbiota transplantation. Open Forum Infect Dis, 2, 2015, ofv004.
26. 26 Norman, J.M., Handley, S.A., Baldridge, M.T., et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160 (2015), 447–460.
27. 27 Li, S.S., Zhu, A., Benes, V., et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
28. 28 Tvede, M., Tinggaard, M., Helms, M., Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012. Clin Microbiol Infect 21 (2015), 48–53.
29. 29 Orenstein, R., Dubberke, E., Hardi, R., et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study. Clin Infect Dis 62 (2016), 596–602.
30. 30 Gerding, D.N., Meyer, T., Lee, C., et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 313 (2015), 1719–1727.
31. 31 Bojanova, D.P., Bordenstein, S.R., Fecal transplants: what is being transferred?. PLoS Biol, 14, 2016, e1002503.
32. 32 Rehman, A., Sina, C., Gavrilova, O., et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 60 (2011), 1354–1362.
33. 33 Fadrosh, D.W., Ma, B., Gajer, P., et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome, 2, 2014, 6.
34. 34 Caporaso, J.G., Lauber, C.L., Walters, W.A., et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6 (2012), 1621–1624.
35. 35 Schloss, P.D., Westcott, S.L., Ryabin, T., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75 (2009), 7537–7541.
36. 36 Edgar, R.C., Haas, B.J., Clemente, J.C., et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27 (2011), 2194–2200.
37. 37 Hammer, O., Harper, D.A.T., Ryan, P.D., Past: paleontological statistics software package for education and data analysis. Palaeontologia Electronica, 4(1), 2001 article 4, pp 1-9.
38. 38 Reyes, A., Haynes, M., Hanson, N., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466 (2010), 334–338.
39. 39 Seekatz, A.M., Aas, J., Gessert, C.E., et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio, 5, 2014 e00893–00814.
40. 40 Fuentes, S., van Nood, E., Tims, S., et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 8 (2014), 1621–1633.
41. 41 Rehman, A., Heinsen, F.A., Koenen, M.E., et al. Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine. BMC Microbiol, 12, 2012, 47.
42. 42 Petrof, E.O., Gloor, G.B., Vanner, S.J., et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating' the gut. Microbiome, 1, 2013, 3.
43. 43 Goldenberg, J.Z., Ma, S.S., Saxton, J.D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev, 5, 2013, CD006095.
44. 44 Wadhwa, A., Al Nahhas, M.F., Dierkhising, R.A., et al. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther 44 (2016), 576–582.
45. 45 Rachmilewitz, D., Katakura, K., Karmeli, F., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126 (2004), 520–528.
46. 46 Rachmilewitz, D., Karmeli, F., Takabayashi, K., et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122 (2002), 1428–1441.
47. 47 Kelly, C.R., Khoruts, A., Staley, C., et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med 165 (2016), 609–616.
48. 48 Chehoud, C., Dryga, A., Hwang, Y., et al. Transfer of viral communities between human individuals during fecal microbiota transplantation. MBio, 7, 2016, e00322.
49. 1 Reyes, A., Haynes, M., Hanson, N., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466 (2010), 334–338.
50. 2 Bolger, A.M., Lohse, M., Usadel, B., Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30 (2014), 2114–2120.
51. 3 Nurk, S., Bankevich, A., Antipov, D., et al. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J Comput Biol 20 (2013), 714–737.
52. 4 Minot, S.S., Krumm, N., Greenfield, N.B., One codex: a sensitive and accurate data platform for genomic microbial identification. bioRxiv, 2015 http://dx.doi.org/10.1101/027607.
53. 5 Xiong, W., Giannone, R.J., Morowitz, M.J., et al. Development of an enhanced metaproteomic approach for deepening the microbiome characterization of the human infant gut. J Proteome Res 14 (2015), 133–141.
54. 6 Wu, J., Zhu, J., Yin, H., et al. Development of an integrated pipeline for profiling microbial proteins from mouse fecal samples by LC-MS/MS. J Proteome Res 15 (2016), 3625–3642.